BioCorRx (OTCMKTS:BICX) Announces Quarterly Earnings Results

BioCorRx (OTCMKTS:BICX) posted its quarterly earnings data on Monday. The company reported ($0.08) earnings per share (EPS) for the quarter, Zacks reports.

BioCorRx Stock Performance

Shares of OTCMKTS BICX traded up $0.06 during midday trading on Monday, reaching $0.41. The company’s stock had a trading volume of 21,208 shares, compared to its average volume of 14,262. The company has a market cap of $6.64 million, a P/E ratio of -0.79 and a beta of 0.57. BioCorRx has a fifty-two week low of $0.26 and a fifty-two week high of $1.50. The business’s 50 day moving average price is $0.39 and its two-hundred day moving average price is $0.37.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.